Craft

Metys Pharmaceuticals

Metys Pharmaceuticals Summary

Company Summary

Overview
Metys Pharmaceuticals is a company that provides treatment for chemotherapy-induced peripheral neuropathy, a side effect of several cancer treatments. It develops MP-101, an orally-active modulator of glutamate signalling in spine and brain that can be used in a range of central nervous system disorders, such as depression, cognition, or neuropathic pain.
Type
Private
Status
Active
Founded
2013
HQ
Basel, CH | view all locations
Website
https://metys-pharma.ch/
Cybersecurity rating
Sectors

Table of Contents

LocationsView all

2 locations detected

  • Basel, BS HQ

    Switzerland

    Gerbergasse 30

  • Basel, BS

    Switzerland

    Steinenring 8

Footer menu